These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6151955)

  • 1. Homologous desensitization of rat heart cells to beta-adrenergic stimulation and the absence of alpha-adrenergic or prostaglandin E1 effects.
    Fisher RA; Harary I; Thomas JA
    J Cyclic Nucleotide Protein Phosphor Res; 1983-1984; 9(6):449-60. PubMed ID: 6151955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ethanol on alpha-adrenergic and beta-adrenergic agonist-stimulated beta-endorphin release and cAMP production in hypothalamic cells in primary cultures.
    De A; Boyadjieva NI; Sarkar DK
    Alcohol Clin Exp Res; 1999 Jan; 23(1):46-51. PubMed ID: 10029202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncoupling of the beta-adrenergic receptor as a mechanism of in vitro neutrophil desensitization.
    Galant SP; Britt S
    J Lab Clin Med; 1984 Feb; 103(2):322-32. PubMed ID: 6319518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of S49 cells in low concentrations of beta-adrenergic agonists causes desensitization.
    Barber R; Goka TJ; Butcher RW
    Mol Pharmacol; 1989 Sep; 36(3):459-64. PubMed ID: 2550779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpah-adrenergic receptor modulation of beta-adrenergic, adenosine and prostaglandin E1 increased adenosine 3':5'-cyclic monophosphate levels in primary cultures of glia.
    McCarthy KD; de Vellis J
    J Cyclic Nucleotide Res; 1978 Feb; 4(1):15-26. PubMed ID: 25289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism.
    Haskó G; Shanley TP; Egnaczyk G; Németh ZH; Salzman AL; Vizi ES; Szabó C
    Br J Pharmacol; 1998 Nov; 125(6):1297-303. PubMed ID: 9863660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adrenertgic agonists on the cyclic AMP levels in atria from euthyroid and hypothyroid rats.
    Simpson WW; NcNeill JH
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):487-97. PubMed ID: 6106962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of VLDL associated triacylglycerol secretion by both alpha- and beta-adrenoceptor agonists in isolated rat hepatocytes.
    Rasouli M; Zahraie M
    Eur J Pharmacol; 2006 Sep; 545(2-3):109-14. PubMed ID: 16876783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of beta receptor mediated cyclic AMP response of cultured fibroblasts by partial agonists.
    Franklin TJ; Twose PA
    J Cyclic Nucleotide Res; 1979; 5(1):19-30. PubMed ID: 35555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of epinephrine and norepinephrine on cAMP response and g(i3)alpha protein expression in cultured sympathetic neurons.
    Shivachar AC; Eikenburg DC
    J Pharmacol Exp Ther; 1999 Oct; 291(1):258-64. PubMed ID: 10490912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
    Nakaki T; Nakadate T; Yamamoto S; Kato R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
    Proll MA; Clark RB; Butcher RW
    Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of beta adrenergic receptors linked to adrenocorticotropin secretion.
    Reisine T; Heisler S
    J Pharmacol Exp Ther; 1983 Oct; 227(1):107-14. PubMed ID: 6137552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vascular smooth muscle cells with estradiol and beta-adrenergic agonists has an additive effect on cAMP levels, but no additive effect on inhibition of collagen synthesis.
    Dimopoulos GJ; Langner RO
    J Pharm Pharmacol; 2005 Aug; 57(8):1005-10. PubMed ID: 16102256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic regulation of cAMP/protein kinase A pathway in corneal epithelium and endothelium.
    Grueb M; Bartz-Schmidt KU; Rohrbach JM
    Ophthalmic Res; 2008 Oct; 40(6):322-8. PubMed ID: 18688175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor produces homologous desensitization of lymphocyte beta 2-adrenergic responses.
    Singh M; Notterman DA; Metakis L
    Circ Shock; 1993 Apr; 39(4):275-8. PubMed ID: 8387402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and bioelectrical effects of cyclic adenosine monophosphate production in the ciliary epithelial bilayer.
    Horio B; Sears M; Mead A; Matsui H; Bausher L
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):607-12. PubMed ID: 8595960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.